Recent advances in the treatment of C. difficile using biotherapeutic agents
Vo Van Giau,1 Hyon Lee,2 Seong Soo A An,1 John Hulme11Department of BioNano Technology, Gachon University, Seongnam-si 461-701, Republic of Korea; 2Department of Neurology, Gachon University Gil Medical Center, Incheon, South KoreaAbstract: Clostridium difficile (C. difficile) is rapidly becoming on...
Main Authors: | Giau VV, Lee H, An SSA, Hulme J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-06-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/recent-advances-in-the-treatment-of-c-difficile-using-biotherapeutic-a-peer-reviewed-article-IDR |
Similar Items
-
Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection
by: Kanika Sehgal, et al.
Published: (2024-05-01) -
Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics
by: Ruojun Wang
Published: (2023-05-01) -
Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection
by: Feuerstadt P, et al.
Published: (2023-08-01) -
Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
by: Nagarakanti S, et al.
Published: (2023-05-01) -
Clinical application of live biotherapeutic products in infectious diseases
by: Bhagyashri D. Navalkele, et al.
Published: (2024-07-01)